4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-058330
Chief Business Officer sold 1,245 shares at $10.72 ($13,346)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan Chief Business Officer | 2023-12-11 | Sale | −1,245 | $10.72 | $13,346 | 155,518 | D |
| Open-market sales · 1,245 sh · avg $10.72 · $13,346 | |||||||
Loading xslF345X05/doc4.xml…